Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 2.

Freeman, George A; Andrews Iii, C Webster; Hopkins, Andrew L; Lowell, Gina S; Schaller, Lee T; Cowan, Jill R; Gonzales, Stephen S; Koszalka, George W; Hazen, Richard J; Boone, Lawrence R; Ferris, Rob G; Creech, Katrina L; Roberts, Grace B; Short, Steven A; Weaver, Kurt; Reynolds, David J; Milton, John; Ren, Jingshan; Stuart, David I; Stammers, David K; Chan, Joseph H

Freeman, George A; Andrews Iii, C Webster; Hopkins, Andrew L; Lowell, Gina S; Schaller, Lee T; Cowan, Jill R; Gonzales, Stephen S; Koszalka, George W; Hazen, Richard J; Boone, Lawrence R; Ferris, Rob G; Creech, Katrina L; Roberts, Grace B; Short, Steven A; Weaver, Kurt; Reynolds, David J; Milton, John; Ren, Jingshan; Stuart, David I; Stammers, David K; Chan, Joseph H.

Affiliation

Freeman GA; GlaxoSmithKline Research and Development, 5 Moore Drive, Research Triangle Park, North Carolina 27709, USA. Andy.A.Freeman@gsk.com

J Med Chem ; 47(24): 5923-36, 2004 Nov 18.

Article in En | MEDLINE | ID: mdl-15537347

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Quinolones / Reverse Transcriptase Inhibitors / Anti-HIV Agents / Drug Resistance, Viral / HIV Reverse Transcriptase Limits: Humans Language: En Journal: J Med Chem Journal subject: QUIMICA Year: 2004 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Search on Google

Add to My VHL

XML

PubMed Links